SPINEWAY |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.855 EUR | +6.86% |
|
-18.40% | -87.43% |
| Apr. 17 | Spineway: punished despite a solid first quarter | CF |
| Apr. 16 | Spineway SA Announces Revenue Results for the First Quarter of 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Spineway designs, produces, and sells spinal column implants and surgical instruments. The group offers spinal systems, cervical and lumbar cages, cervical plates, bone substitutes, etc.
Net sales are distributed geographically as follows: France (27.8%), Europe (21.4%), Latin America (29.8%), Asia (16.1%) and the Middle East and Africa (4.9%).
Calendar
2024-04-28
- Q4 2023 Earnings Release (Projected)
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.855
EUR
Average target price
1.8
EUR
Spread / Average Target
+110.53%
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -87.43% | 760K | |
| -2.31% | 187B | |
| -3.20% | 106B | |
| -5.04% | 66.9B | |
| +0.20% | 49.45B | |
| +17.29% | 48B | |
| +4.06% | 40.84B | |
| +2.07% | 26.48B | |
| +2.36% | 26.25B | |
| +12.96% | 24.62B |
- Stock Market
- Equities
- ALSPW Stock
- News Spineway
- Surgical Implants Group Spineway To Launch Reverse Stock Split
